Literature DB >> 16491723

Is there a role for high-frequency ultrasonography in clinical staging of retinopathy of prematurity?

Danny H Kauffinann Jokl1, Ronald H Silverman, Sheri L Nemerofiky, Steven A Kane, Michael F Chiang, Robert Lopez, Grace Lee.   

Abstract

PURPOSE: To compare 20-MHz ultrasonography with ophthalmoscopy in the staging of retinopathy of prematurity (ROP).
METHODS: We used a handheld 20-MHz ultrasound system to examine 38 eyes of 19 neonates who had an indirect ophthalmoscopic examination (diagnosis masked) within 48 hours prior to ultrasonography. Determination of ROP by indirect ophthalmoscopy was compared with independent identification of ultrasonic features indicative of ROP stages.
RESULTS: In masked cases, ultrasonography correctly identified 13 of 18 (72.2% sensitivity) eyes with zone 2, stage 2 ROP or worse and 19 of 20 (95.0% specificity) normal eyes (zone 2, stage 1 ROP or better) (chi-square, 18.4; P < .001).
CONCLUSION: In the neonatal nursery, a 20-MHz handheld ultrasound system may be an effective screening tool to initially identify ROP for further ophthalmoscopic evaluation and management.

Entities:  

Mesh:

Year:  2006        PMID: 16491723      PMCID: PMC1618793          DOI: 10.3928/01913913-20060101-04

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  20 in total

1.  The future of screening for retinopathy of prematurity.

Authors:  Richard A Saunders; Amy K Hutchinson
Journal:  J AAPOS       Date:  2002-04       Impact factor: 1.220

2.  Retinopathy of prematurity.

Authors:  S P Donahue
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

3.  Comparison of ultrasonic and ophthalmoscopic evaluation of retinopathy of prematurity.

Authors:  Danny H Kauffmann Jokl; Ronald H Silverman; Alan D Springer; Helen Towers; Steven Kane; Robert Lopez; Michael F Chiang; Harriet O Lloyd; Irene Barbazetto; Robyn Horowitz; Orit Vidne
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2004 Nov-Dec       Impact factor: 1.402

4.  Ultrasound biomicroscopy in the screening of retinopathy of prematurity.

Authors:  Michael H Brent; Charles J Pavlin; Edmond N Kelly
Journal:  Am J Ophthalmol       Date:  2002-02       Impact factor: 5.258

5.  Retinopathy of prematurity screening, stress related responses, the role of nesting.

Authors:  M Slevin; J F Murphy; L Daly; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

6.  Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera.

Authors:  S D Schwartz; S A Harrison; P J Ferrone; M T Trese
Journal:  Ophthalmology       Date:  2000-01       Impact factor: 12.079

7.  Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-08

8.  Screening for retinopathy of prematurity employing the retcam 120: sensitivity and specificity.

Authors:  D B Roth; D Morales; W J Feuer; D Hess; R A Johnson; J T Flynn
Journal:  Arch Ophthalmol       Date:  2001-02

9.  Screening for retinopathy of prematurity: evaluation and modification of guidelines.

Authors:  E Larsson; G Holmström
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

10.  Stress induced by screening for retinopathy of prematurity.

Authors:  Harsh Kumar; Sanjeev Nainiwal; Ujwala Singha; Rajvardhan Azad; V K Paul
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2002 Nov-Dec       Impact factor: 1.402

View more
  2 in total

Review 1.  Systematic review of digital imaging screening strategies for retinopathy of prematurity.

Authors:  Alex R Kemper; David K Wallace; Graham E Quinn
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

2.  Ocular Blood Flow in Preterm Neonates: A Preliminary Report.

Authors:  Ronald H Silverman; Raksha Urs; Danny H-Kauffmann Jokl; Leora Pinto; Osode Coki; Rakesh Sahni; Jason D Horowitz; Steven E Brooks
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.